nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—CYP2D6—Lomustine—brain cancer	0.101	0.271	CbGbCtD
Paliperidone—CYP2D6—Hydroxyurea—brain cancer	0.0765	0.205	CbGbCtD
Paliperidone—CYP3A4—Temozolomide—brain cancer	0.0755	0.203	CbGbCtD
Paliperidone—CYP3A4—Lomustine—brain cancer	0.0642	0.172	CbGbCtD
Paliperidone—CYP3A5—Etoposide—brain cancer	0.0398	0.107	CbGbCtD
Paliperidone—HTR1D—meninx—brain cancer	0.0204	0.0741	CbGeAlD
Paliperidone—HTR1B—dura mater—brain cancer	0.0194	0.0704	CbGeAlD
Paliperidone—HTR1D—dura mater—brain cancer	0.0188	0.0682	CbGeAlD
Paliperidone—HTR2C—choroid plexus—brain cancer	0.0158	0.0574	CbGeAlD
Paliperidone—CYP3A4—Etoposide—brain cancer	0.0155	0.0417	CbGbCtD
Paliperidone—HTR1B—trigeminal nerve—brain cancer	0.00836	0.0303	CbGeAlD
Paliperidone—DRD3—telencephalic ventricle—brain cancer	0.00835	0.0302	CbGeAlD
Paliperidone—HTR1D—trigeminal nerve—brain cancer	0.00809	0.0293	CbGeAlD
Paliperidone—HTR2A—choroid plexus—brain cancer	0.00795	0.0288	CbGeAlD
Paliperidone—HRH1—nose—brain cancer	0.00613	0.0222	CbGeAlD
Paliperidone—DRD1—telencephalic ventricle—brain cancer	0.00598	0.0216	CbGeAlD
Paliperidone—HTR1B—cranial nerve—brain cancer	0.00596	0.0216	CbGeAlD
Paliperidone—HTR1D—cranial nerve—brain cancer	0.00577	0.0209	CbGeAlD
Paliperidone—HTR1B—telencephalic ventricle—brain cancer	0.00484	0.0175	CbGeAlD
Paliperidone—HTR1D—telencephalic ventricle—brain cancer	0.00469	0.017	CbGeAlD
Paliperidone—HTR2C—telencephalic ventricle—brain cancer	0.00464	0.0168	CbGeAlD
Paliperidone—HTR2A—trigeminal nerve—brain cancer	0.00402	0.0146	CbGeAlD
Paliperidone—HTR2A—cerebellar cortex—brain cancer	0.004	0.0145	CbGeAlD
Paliperidone—HTR1A—telencephalic ventricle—brain cancer	0.00391	0.0142	CbGeAlD
Paliperidone—DRD1—ganglion—brain cancer	0.00372	0.0135	CbGeAlD
Paliperidone—HTR2A—vein—brain cancer	0.00363	0.0132	CbGeAlD
Paliperidone—DRD2—telencephalic ventricle—brain cancer	0.00353	0.0128	CbGeAlD
Paliperidone—HTR1B—ganglion—brain cancer	0.00301	0.0109	CbGeAlD
Paliperidone—HTR1D—ganglion—brain cancer	0.00292	0.0106	CbGeAlD
Paliperidone—HTR2C—ganglion—brain cancer	0.00289	0.0105	CbGeAlD
Paliperidone—HTR2A—cranial nerve—brain cancer	0.00286	0.0104	CbGeAlD
Paliperidone—HTR2A—pons—brain cancer	0.00283	0.0103	CbGeAlD
Paliperidone—HTR1A—ganglion—brain cancer	0.00243	0.00881	CbGeAlD
Paliperidone—HTR1B—blood vessel—brain cancer	0.0024	0.00868	CbGeAlD
Paliperidone—HTR2A—telencephalic ventricle—brain cancer	0.00233	0.00844	CbGeAlD
Paliperidone—HTR1D—blood vessel—brain cancer	0.00232	0.00841	CbGeAlD
Paliperidone—DRD2—ganglion—brain cancer	0.0022	0.00796	CbGeAlD
Paliperidone—HTR2A—pineal body—brain cancer	0.00202	0.00732	CbGeAlD
Paliperidone—HTR1A—hindbrain—brain cancer	0.00184	0.00668	CbGeAlD
Paliperidone—ADRA1A—hindbrain—brain cancer	0.0017	0.00616	CbGeAlD
Paliperidone—DRD2—hindbrain—brain cancer	0.00167	0.00604	CbGeAlD
Paliperidone—DRD1—brainstem—brain cancer	0.00162	0.00586	CbGeAlD
Paliperidone—HTR2A—ganglion—brain cancer	0.00145	0.00525	CbGeAlD
Paliperidone—DRD1—telencephalon—brain cancer	0.00143	0.0052	CbGeAlD
Paliperidone—HTR1B—brainstem—brain cancer	0.00131	0.00475	CbGeAlD
Paliperidone—DRD4—brain—brain cancer	0.00129	0.00466	CbGeAlD
Paliperidone—HTR1D—brainstem—brain cancer	0.00127	0.0046	CbGeAlD
Paliperidone—HTR2C—brainstem—brain cancer	0.00126	0.00455	CbGeAlD
Paliperidone—HTR2A—endothelium—brain cancer	0.00125	0.00453	CbGeAlD
Paliperidone—DRD3—head—brain cancer	0.00125	0.00452	CbGeAlD
Paliperidone—HTR1B—telencephalon—brain cancer	0.00116	0.00421	CbGeAlD
Paliperidone—HTR2A—blood vessel—brain cancer	0.00115	0.00418	CbGeAlD
Paliperidone—DRD3—central nervous system—brain cancer	0.00114	0.00413	CbGeAlD
Paliperidone—HTR1D—telencephalon—brain cancer	0.00113	0.00408	CbGeAlD
Paliperidone—HTR2C—telencephalon—brain cancer	0.00111	0.00404	CbGeAlD
Paliperidone—HTR2A—hindbrain—brain cancer	0.0011	0.00398	CbGeAlD
Paliperidone—HTR1A—brainstem—brain cancer	0.00106	0.00383	CbGeAlD
Paliperidone—DRD1—midbrain—brain cancer	0.00103	0.00373	CbGeAlD
Paliperidone—CYP2D6—hindbrain—brain cancer	0.001	0.00363	CbGeAlD
Paliperidone—ADRA1A—brainstem—brain cancer	0.000975	0.00353	CbGeAlD
Paliperidone—ADRA1B—head—brain cancer	0.000959	0.00347	CbGeAlD
Paliperidone—DRD2—brainstem—brain cancer	0.000955	0.00346	CbGeAlD
Paliperidone—HTR1A—telencephalon—brain cancer	0.000938	0.0034	CbGeAlD
Paliperidone—DRD3—brain—brain cancer	0.000904	0.00328	CbGeAlD
Paliperidone—DRD1—head—brain cancer	0.000894	0.00324	CbGeAlD
Paliperidone—HTR2C—medulla oblongata—brain cancer	0.000876	0.00317	CbGeAlD
Paliperidone—ADRA1B—central nervous system—brain cancer	0.000875	0.00317	CbGeAlD
Paliperidone—ADRA1A—telencephalon—brain cancer	0.000865	0.00313	CbGeAlD
Paliperidone—DRD2—telencephalon—brain cancer	0.000848	0.00307	CbGeAlD
Paliperidone—HTR1B—midbrain—brain cancer	0.000835	0.00302	CbGeAlD
Paliperidone—ADRA2C—telencephalon—brain cancer	0.000824	0.00299	CbGeAlD
Paliperidone—DRD1—central nervous system—brain cancer	0.000816	0.00295	CbGeAlD
Paliperidone—HTR1B—spinal cord—brain cancer	0.000815	0.00295	CbGeAlD
Paliperidone—HTR1D—midbrain—brain cancer	0.000808	0.00293	CbGeAlD
Paliperidone—HTR2C—midbrain—brain cancer	0.000801	0.0029	CbGeAlD
Paliperidone—HTR2C—spinal cord—brain cancer	0.000781	0.00283	CbGeAlD
Paliperidone—HTR1B—endocrine gland—brain cancer	0.000733	0.00266	CbGeAlD
Paliperidone—HTR1B—head—brain cancer	0.000724	0.00262	CbGeAlD
Paliperidone—HTR1D—head—brain cancer	0.000701	0.00254	CbGeAlD
Paliperidone—ADRA1B—brain—brain cancer	0.000695	0.00252	CbGeAlD
Paliperidone—HTR2C—head—brain cancer	0.000694	0.00251	CbGeAlD
Paliperidone—DRD2—pituitary gland—brain cancer	0.00069	0.0025	CbGeAlD
Paliperidone—HTR1A—midbrain—brain cancer	0.000674	0.00244	CbGeAlD
Paliperidone—ADRA2C—pituitary gland—brain cancer	0.000671	0.00243	CbGeAlD
Paliperidone—HRH1—telencephalon—brain cancer	0.00067	0.00243	CbGeAlD
Paliperidone—HTR1B—central nervous system—brain cancer	0.000661	0.00239	CbGeAlD
Paliperidone—ADRA2A—telencephalon—brain cancer	0.000658	0.00238	CbGeAlD
Paliperidone—HTR1A—spinal cord—brain cancer	0.000657	0.00238	CbGeAlD
Paliperidone—ADRA2C—medulla oblongata—brain cancer	0.000648	0.00235	CbGeAlD
Paliperidone—DRD1—brain—brain cancer	0.000648	0.00235	CbGeAlD
Paliperidone—HTR1D—central nervous system—brain cancer	0.00064	0.00232	CbGeAlD
Paliperidone—HTR2C—central nervous system—brain cancer	0.000634	0.0023	CbGeAlD
Paliperidone—HTR2A—brainstem—brain cancer	0.00063	0.00228	CbGeAlD
Paliperidone—Infestation—Temozolomide—brain cancer	0.000615	0.00226	CcSEcCtD
Paliperidone—Depression—Temozolomide—brain cancer	0.000613	0.00225	CcSEcCtD
Paliperidone—DRD2—midbrain—brain cancer	0.000609	0.00221	CbGeAlD
Paliperidone—Cardiac arrest—Etoposide—brain cancer	0.000607	0.00223	CcSEcCtD
Paliperidone—Nausea—Lomustine—brain cancer	0.000607	0.00223	CcSEcCtD
Paliperidone—Hypotension—Procarbazine—brain cancer	0.000606	0.00223	CcSEcCtD
Paliperidone—Urinary tract infection—Temozolomide—brain cancer	0.000597	0.00219	CcSEcCtD
Paliperidone—ADRA2C—midbrain—brain cancer	0.000592	0.00214	CbGeAlD
Paliperidone—HTR1A—endocrine gland—brain cancer	0.000592	0.00214	CbGeAlD
Paliperidone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000591	0.00217	CcSEcCtD
Paliperidone—Insomnia—Procarbazine—brain cancer	0.000586	0.00215	CcSEcCtD
Paliperidone—HTR1A—head—brain cancer	0.000584	0.00212	CbGeAlD
Paliperidone—Paraesthesia—Procarbazine—brain cancer	0.000582	0.00214	CcSEcCtD
Paliperidone—Hepatobiliary disease—Temozolomide—brain cancer	0.000581	0.00214	CcSEcCtD
Paliperidone—ADRA2C—spinal cord—brain cancer	0.000577	0.00209	CbGeAlD
Paliperidone—Sinusitis—Temozolomide—brain cancer	0.000577	0.00212	CcSEcCtD
Paliperidone—Somnolence—Procarbazine—brain cancer	0.000576	0.00212	CcSEcCtD
Paliperidone—CYP2D6—brainstem—brain cancer	0.000574	0.00208	CbGeAlD
Paliperidone—Ill-defined disorder—Hydroxyurea—brain cancer	0.000571	0.0021	CcSEcCtD
Paliperidone—Anaemia—Hydroxyurea—brain cancer	0.000568	0.00209	CcSEcCtD
Paliperidone—Hypoaesthesia—Carmustine—brain cancer	0.000568	0.00209	CcSEcCtD
Paliperidone—Decreased appetite—Procarbazine—brain cancer	0.000564	0.00207	CcSEcCtD
Paliperidone—Alanine aminotransferase increased—Etoposide—brain cancer	0.000563	0.00207	CcSEcCtD
Paliperidone—Oedema peripheral—Carmustine—brain cancer	0.000563	0.00207	CcSEcCtD
Paliperidone—Connective tissue disorder—Carmustine—brain cancer	0.000561	0.00206	CcSEcCtD
Paliperidone—HTR2A—telencephalon—brain cancer	0.000559	0.00203	CbGeAlD
Paliperidone—Fatigue—Procarbazine—brain cancer	0.000559	0.00205	CcSEcCtD
Paliperidone—Malaise—Hydroxyurea—brain cancer	0.000555	0.00204	CcSEcCtD
Paliperidone—Pain—Procarbazine—brain cancer	0.000555	0.00204	CcSEcCtD
Paliperidone—Constipation—Procarbazine—brain cancer	0.000555	0.00204	CcSEcCtD
Paliperidone—Dysphagia—Etoposide—brain cancer	0.000552	0.00203	CcSEcCtD
Paliperidone—Leukopenia—Hydroxyurea—brain cancer	0.00055	0.00202	CcSEcCtD
Paliperidone—Hypoaesthesia—Temozolomide—brain cancer	0.000549	0.00202	CcSEcCtD
Paliperidone—ADRA2A—gonad—brain cancer	0.000549	0.00199	CbGeAlD
Paliperidone—ADRA1A—endocrine gland—brain cancer	0.000546	0.00198	CbGeAlD
Paliperidone—Urinary tract disorder—Temozolomide—brain cancer	0.000545	0.002	CcSEcCtD
Paliperidone—Oedema peripheral—Temozolomide—brain cancer	0.000544	0.002	CcSEcCtD
Paliperidone—Connective tissue disorder—Temozolomide—brain cancer	0.000542	0.00199	CcSEcCtD
Paliperidone—Urethral disorder—Temozolomide—brain cancer	0.000541	0.00199	CcSEcCtD
Paliperidone—ADRA1A—head—brain cancer	0.000539	0.00195	CbGeAlD
Paliperidone—ADRA2A—pituitary gland—brain cancer	0.000535	0.00194	CbGeAlD
Paliperidone—DRD2—endocrine gland—brain cancer	0.000535	0.00194	CbGeAlD
Paliperidone—Feeling abnormal—Procarbazine—brain cancer	0.000534	0.00196	CcSEcCtD
Paliperidone—Eye disorder—Carmustine—brain cancer	0.000534	0.00196	CcSEcCtD
Paliperidone—HTR1A—central nervous system—brain cancer	0.000533	0.00193	CbGeAlD
Paliperidone—Convulsion—Hydroxyurea—brain cancer	0.000533	0.00196	CcSEcCtD
Paliperidone—Gastrointestinal pain—Procarbazine—brain cancer	0.00053	0.00195	CcSEcCtD
Paliperidone—Flushing—Carmustine—brain cancer	0.00053	0.00195	CcSEcCtD
Paliperidone—DRD2—head—brain cancer	0.000528	0.00191	CbGeAlD
Paliperidone—HTR1B—brain—brain cancer	0.000525	0.0019	CbGeAlD
Paliperidone—HTR1A—cerebellum—brain cancer	0.000521	0.00189	CbGeAlD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00052	0.00191	CcSEcCtD
Paliperidone—Discomfort—Hydroxyurea—brain cancer	0.000517	0.0019	CcSEcCtD
Paliperidone—ADRA2A—medulla oblongata—brain cancer	0.000517	0.00187	CbGeAlD
Paliperidone—Neutropenia—Etoposide—brain cancer	0.000516	0.00189	CcSEcCtD
Paliperidone—Eye disorder—Temozolomide—brain cancer	0.000516	0.00189	CcSEcCtD
Paliperidone—Urticaria—Procarbazine—brain cancer	0.000515	0.00189	CcSEcCtD
Paliperidone—Tinnitus—Temozolomide—brain cancer	0.000514	0.00189	CcSEcCtD
Paliperidone—ADRA2C—head—brain cancer	0.000513	0.00186	CbGeAlD
Paliperidone—Abdominal pain—Procarbazine—brain cancer	0.000513	0.00188	CcSEcCtD
Paliperidone—Body temperature increased—Procarbazine—brain cancer	0.000513	0.00188	CcSEcCtD
Paliperidone—Flushing—Temozolomide—brain cancer	0.000512	0.00188	CcSEcCtD
Paliperidone—Cardiac disorder—Temozolomide—brain cancer	0.000512	0.00188	CcSEcCtD
Paliperidone—CYP2D6—telencephalon—brain cancer	0.000509	0.00185	CbGeAlD
Paliperidone—HTR1D—brain—brain cancer	0.000508	0.00184	CbGeAlD
Paliperidone—Alopecia—Carmustine—brain cancer	0.000505	0.00185	CcSEcCtD
Paliperidone—HTR2C—brain—brain cancer	0.000503	0.00182	CbGeAlD
Paliperidone—Oedema—Hydroxyurea—brain cancer	0.000502	0.00184	CcSEcCtD
Paliperidone—Angiopathy—Temozolomide—brain cancer	0.000501	0.00184	CcSEcCtD
Paliperidone—Mental disorder—Carmustine—brain cancer	0.0005	0.00184	CcSEcCtD
Paliperidone—Infection—Hydroxyurea—brain cancer	0.000499	0.00183	CcSEcCtD
Paliperidone—Immune system disorder—Temozolomide—brain cancer	0.000498	0.00183	CcSEcCtD
Paliperidone—Mediastinal disorder—Temozolomide—brain cancer	0.000497	0.00183	CcSEcCtD
Paliperidone—Malnutrition—Carmustine—brain cancer	0.000497	0.00183	CcSEcCtD
Paliperidone—Erythema—Carmustine—brain cancer	0.000497	0.00183	CcSEcCtD
Paliperidone—Chills—Temozolomide—brain cancer	0.000495	0.00182	CcSEcCtD
Paliperidone—Pneumonia—Etoposide—brain cancer	0.000495	0.00182	CcSEcCtD
Paliperidone—Nervous system disorder—Hydroxyurea—brain cancer	0.000492	0.00181	CcSEcCtD
Paliperidone—Infestation—Etoposide—brain cancer	0.000492	0.00181	CcSEcCtD
Paliperidone—Infestation NOS—Etoposide—brain cancer	0.000492	0.00181	CcSEcCtD
Paliperidone—ADRA1A—central nervous system—brain cancer	0.000492	0.00178	CbGeAlD
Paliperidone—Thrombocytopenia—Hydroxyurea—brain cancer	0.000491	0.0018	CcSEcCtD
Paliperidone—Alopecia—Temozolomide—brain cancer	0.000488	0.00179	CcSEcCtD
Paliperidone—Skin disorder—Hydroxyurea—brain cancer	0.000487	0.00179	CcSEcCtD
Paliperidone—Mental disorder—Temozolomide—brain cancer	0.000483	0.00178	CcSEcCtD
Paliperidone—DRD2—central nervous system—brain cancer	0.000482	0.00175	CbGeAlD
Paliperidone—Back pain—Carmustine—brain cancer	0.000481	0.00177	CcSEcCtD
Paliperidone—ADRA1A—cerebellum—brain cancer	0.000481	0.00174	CbGeAlD
Paliperidone—Erythema—Temozolomide—brain cancer	0.00048	0.00176	CcSEcCtD
Paliperidone—Malnutrition—Temozolomide—brain cancer	0.00048	0.00176	CcSEcCtD
Paliperidone—Jaundice—Etoposide—brain cancer	0.000479	0.00176	CcSEcCtD
Paliperidone—Anorexia—Hydroxyurea—brain cancer	0.000478	0.00176	CcSEcCtD
Paliperidone—Hypersensitivity—Procarbazine—brain cancer	0.000478	0.00175	CcSEcCtD
Paliperidone—ADRA2A—midbrain—brain cancer	0.000472	0.00171	CbGeAlD
Paliperidone—DRD2—cerebellum—brain cancer	0.000471	0.00171	CbGeAlD
Paliperidone—Dysgeusia—Temozolomide—brain cancer	0.00047	0.00173	CcSEcCtD
Paliperidone—Vision blurred—Carmustine—brain cancer	0.000468	0.00172	CcSEcCtD
Paliperidone—ADRA2C—central nervous system—brain cancer	0.000468	0.0017	CbGeAlD
Paliperidone—HTR2A—gonad—brain cancer	0.000467	0.00169	CbGeAlD
Paliperidone—Tremor—Carmustine—brain cancer	0.000466	0.00171	CcSEcCtD
Paliperidone—Asthenia—Procarbazine—brain cancer	0.000465	0.00171	CcSEcCtD
Paliperidone—Hepatobiliary disease—Etoposide—brain cancer	0.000465	0.00171	CcSEcCtD
Paliperidone—Back pain—Temozolomide—brain cancer	0.000465	0.00171	CcSEcCtD
Paliperidone—ADRA2A—spinal cord—brain cancer	0.000461	0.00167	CbGeAlD
Paliperidone—Anaemia—Carmustine—brain cancer	0.000459	0.00169	CcSEcCtD
Paliperidone—Agranulocytosis—Etoposide—brain cancer	0.000459	0.00169	CcSEcCtD
Paliperidone—Pruritus—Procarbazine—brain cancer	0.000459	0.00169	CcSEcCtD
Paliperidone—ADRA2C—cerebellum—brain cancer	0.000458	0.00166	CbGeAlD
Paliperidone—Agitation—Carmustine—brain cancer	0.000457	0.00168	CcSEcCtD
Paliperidone—HTR2A—pituitary gland—brain cancer	0.000455	0.00165	CbGeAlD
Paliperidone—Vision blurred—Temozolomide—brain cancer	0.000453	0.00166	CcSEcCtD
Paliperidone—Tremor—Temozolomide—brain cancer	0.00045	0.00165	CcSEcCtD
Paliperidone—Dyspnoea—Hydroxyurea—brain cancer	0.000447	0.00164	CcSEcCtD
Paliperidone—Somnolence—Hydroxyurea—brain cancer	0.000446	0.00164	CcSEcCtD
Paliperidone—Ill-defined disorder—Temozolomide—brain cancer	0.000446	0.00164	CcSEcCtD
Paliperidone—Leukopenia—Carmustine—brain cancer	0.000445	0.00163	CcSEcCtD
Paliperidone—Anaemia—Temozolomide—brain cancer	0.000444	0.00163	CcSEcCtD
Paliperidone—Diarrhoea—Procarbazine—brain cancer	0.000444	0.00163	CcSEcCtD
Paliperidone—Dyspepsia—Hydroxyurea—brain cancer	0.000442	0.00162	CcSEcCtD
Paliperidone—Agitation—Temozolomide—brain cancer	0.000441	0.00162	CcSEcCtD
Paliperidone—HTR2A—medulla oblongata—brain cancer	0.000439	0.00159	CbGeAlD
Paliperidone—Hypoaesthesia—Etoposide—brain cancer	0.000439	0.00161	CcSEcCtD
Paliperidone—Angioedema—Temozolomide—brain cancer	0.000439	0.00161	CcSEcCtD
Paliperidone—Decreased appetite—Hydroxyurea—brain cancer	0.000436	0.0016	CcSEcCtD
Paliperidone—Urinary tract disorder—Etoposide—brain cancer	0.000436	0.0016	CcSEcCtD
Paliperidone—CYP3A5—endocrine gland—brain cancer	0.000435	0.00158	CbGeAlD
Paliperidone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000433	0.00159	CcSEcCtD
Paliperidone—Malaise—Temozolomide—brain cancer	0.000433	0.00159	CcSEcCtD
Paliperidone—Urethral disorder—Etoposide—brain cancer	0.000433	0.00159	CcSEcCtD
Paliperidone—Fatigue—Hydroxyurea—brain cancer	0.000433	0.00159	CcSEcCtD
Paliperidone—Vertigo—Temozolomide—brain cancer	0.000432	0.00159	CcSEcCtD
Paliperidone—Convulsion—Carmustine—brain cancer	0.000431	0.00158	CcSEcCtD
Paliperidone—Leukopenia—Temozolomide—brain cancer	0.00043	0.00158	CcSEcCtD
Paliperidone—Hypertension—Carmustine—brain cancer	0.000429	0.00158	CcSEcCtD
Paliperidone—Pain—Hydroxyurea—brain cancer	0.000429	0.00158	CcSEcCtD
Paliperidone—Constipation—Hydroxyurea—brain cancer	0.000429	0.00158	CcSEcCtD
Paliperidone—Dizziness—Procarbazine—brain cancer	0.000429	0.00157	CcSEcCtD
Paliperidone—Palpitations—Temozolomide—brain cancer	0.000425	0.00156	CcSEcCtD
Paliperidone—HTR1A—brain—brain cancer	0.000423	0.00153	CbGeAlD
Paliperidone—Myalgia—Carmustine—brain cancer	0.000423	0.00155	CcSEcCtD
Paliperidone—Chest pain—Carmustine—brain cancer	0.000423	0.00155	CcSEcCtD
Paliperidone—HRH1—endocrine gland—brain cancer	0.000422	0.00153	CbGeAlD
Paliperidone—Anxiety—Carmustine—brain cancer	0.000422	0.00155	CcSEcCtD
Paliperidone—Cough—Temozolomide—brain cancer	0.000419	0.00154	CcSEcCtD
Paliperidone—HRH1—head—brain cancer	0.000417	0.00151	CbGeAlD
Paliperidone—Convulsion—Temozolomide—brain cancer	0.000416	0.00153	CcSEcCtD
Paliperidone—ADRA2A—endocrine gland—brain cancer	0.000415	0.0015	CbGeAlD
Paliperidone—Hypertension—Temozolomide—brain cancer	0.000415	0.00152	CcSEcCtD
Paliperidone—Feeling abnormal—Hydroxyurea—brain cancer	0.000414	0.00152	CcSEcCtD
Paliperidone—Eye disorder—Etoposide—brain cancer	0.000413	0.00152	CcSEcCtD
Paliperidone—Vomiting—Procarbazine—brain cancer	0.000412	0.00151	CcSEcCtD
Paliperidone—Flushing—Etoposide—brain cancer	0.00041	0.00151	CcSEcCtD
Paliperidone—Cardiac disorder—Etoposide—brain cancer	0.00041	0.00151	CcSEcCtD
Paliperidone—ADRA2A—head—brain cancer	0.00041	0.00148	CbGeAlD
Paliperidone—Confusional state—Carmustine—brain cancer	0.000409	0.0015	CcSEcCtD
Paliperidone—Myalgia—Temozolomide—brain cancer	0.000409	0.0015	CcSEcCtD
Paliperidone—Arthralgia—Temozolomide—brain cancer	0.000409	0.0015	CcSEcCtD
Paliperidone—Rash—Procarbazine—brain cancer	0.000409	0.0015	CcSEcCtD
Paliperidone—Dermatitis—Procarbazine—brain cancer	0.000408	0.0015	CcSEcCtD
Paliperidone—Anxiety—Temozolomide—brain cancer	0.000408	0.0015	CcSEcCtD
Paliperidone—Headache—Procarbazine—brain cancer	0.000406	0.00149	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000406	0.00149	CcSEcCtD
Paliperidone—Oedema—Carmustine—brain cancer	0.000406	0.00149	CcSEcCtD
Paliperidone—Discomfort—Temozolomide—brain cancer	0.000404	0.00148	CcSEcCtD
Paliperidone—Infection—Carmustine—brain cancer	0.000403	0.00148	CcSEcCtD
Paliperidone—HTR2A—midbrain—brain cancer	0.000402	0.00145	CbGeAlD
Paliperidone—Angiopathy—Etoposide—brain cancer	0.000401	0.00147	CcSEcCtD
Paliperidone—Dry mouth—Temozolomide—brain cancer	0.0004	0.00147	CcSEcCtD
Paliperidone—Immune system disorder—Etoposide—brain cancer	0.000399	0.00146	CcSEcCtD
Paliperidone—Mediastinal disorder—Etoposide—brain cancer	0.000398	0.00146	CcSEcCtD
Paliperidone—Thrombocytopenia—Carmustine—brain cancer	0.000397	0.00146	CcSEcCtD
Paliperidone—Body temperature increased—Hydroxyurea—brain cancer	0.000397	0.00146	CcSEcCtD
Paliperidone—Chills—Etoposide—brain cancer	0.000396	0.00146	CcSEcCtD
Paliperidone—Tachycardia—Carmustine—brain cancer	0.000396	0.00145	CcSEcCtD
Paliperidone—Confusional state—Temozolomide—brain cancer	0.000395	0.00145	CcSEcCtD
Paliperidone—Anaphylactic shock—Temozolomide—brain cancer	0.000392	0.00144	CcSEcCtD
Paliperidone—Oedema—Temozolomide—brain cancer	0.000392	0.00144	CcSEcCtD
Paliperidone—HTR2A—spinal cord—brain cancer	0.000392	0.00142	CbGeAlD
Paliperidone—ADRA1A—brain—brain cancer	0.00039	0.00141	CbGeAlD
Paliperidone—Alopecia—Etoposide—brain cancer	0.00039	0.00143	CcSEcCtD
Paliperidone—Infection—Temozolomide—brain cancer	0.000389	0.00143	CcSEcCtD
Paliperidone—Anorexia—Carmustine—brain cancer	0.000387	0.00142	CcSEcCtD
Paliperidone—Nausea—Procarbazine—brain cancer	0.000385	0.00141	CcSEcCtD
Paliperidone—Nervous system disorder—Temozolomide—brain cancer	0.000384	0.00141	CcSEcCtD
Paliperidone—Thrombocytopenia—Temozolomide—brain cancer	0.000384	0.00141	CcSEcCtD
Paliperidone—DRD2—brain—brain cancer	0.000383	0.00139	CbGeAlD
Paliperidone—Skin disorder—Temozolomide—brain cancer	0.000381	0.0014	CcSEcCtD
Paliperidone—HRH1—central nervous system—brain cancer	0.000381	0.00138	CbGeAlD
Paliperidone—Hypotension—Carmustine—brain cancer	0.000379	0.00139	CcSEcCtD
Paliperidone—Dysgeusia—Etoposide—brain cancer	0.000376	0.00138	CcSEcCtD
Paliperidone—ADRA2A—central nervous system—brain cancer	0.000374	0.00135	CbGeAlD
Paliperidone—Anorexia—Temozolomide—brain cancer	0.000374	0.00137	CcSEcCtD
Paliperidone—ADRA2C—brain—brain cancer	0.000372	0.00135	CbGeAlD
Paliperidone—Back pain—Etoposide—brain cancer	0.000372	0.00137	CcSEcCtD
Paliperidone—Hypersensitivity—Hydroxyurea—brain cancer	0.00037	0.00136	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Carmustine—brain cancer	0.00037	0.00136	CcSEcCtD
Paliperidone—Muscle spasms—Etoposide—brain cancer	0.00037	0.00136	CcSEcCtD
Paliperidone—Insomnia—Carmustine—brain cancer	0.000367	0.00135	CcSEcCtD
Paliperidone—ADRA2A—cerebellum—brain cancer	0.000365	0.00132	CbGeAlD
Paliperidone—Paraesthesia—Carmustine—brain cancer	0.000364	0.00134	CcSEcCtD
Paliperidone—Dyspnoea—Carmustine—brain cancer	0.000362	0.00133	CcSEcCtD
Paliperidone—Somnolence—Carmustine—brain cancer	0.000361	0.00132	CcSEcCtD
Paliperidone—Asthenia—Hydroxyurea—brain cancer	0.00036	0.00132	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000357	0.00131	CcSEcCtD
Paliperidone—Ill-defined disorder—Etoposide—brain cancer	0.000357	0.00131	CcSEcCtD
Paliperidone—Anaemia—Etoposide—brain cancer	0.000355	0.0013	CcSEcCtD
Paliperidone—Insomnia—Temozolomide—brain cancer	0.000355	0.0013	CcSEcCtD
Paliperidone—HTR2A—endocrine gland—brain cancer	0.000353	0.00128	CbGeAlD
Paliperidone—Decreased appetite—Carmustine—brain cancer	0.000353	0.0013	CcSEcCtD
Paliperidone—Paraesthesia—Temozolomide—brain cancer	0.000352	0.00129	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Carmustine—brain cancer	0.00035	0.00129	CcSEcCtD
Paliperidone—Dyspnoea—Temozolomide—brain cancer	0.00035	0.00128	CcSEcCtD
Paliperidone—Somnolence—Temozolomide—brain cancer	0.000349	0.00128	CcSEcCtD
Paliperidone—HTR2A—head—brain cancer	0.000348	0.00126	CbGeAlD
Paliperidone—Pain—Carmustine—brain cancer	0.000347	0.00127	CcSEcCtD
Paliperidone—Constipation—Carmustine—brain cancer	0.000347	0.00127	CcSEcCtD
Paliperidone—Malaise—Etoposide—brain cancer	0.000347	0.00127	CcSEcCtD
Paliperidone—Vertigo—Etoposide—brain cancer	0.000345	0.00127	CcSEcCtD
Paliperidone—Dyspepsia—Temozolomide—brain cancer	0.000345	0.00127	CcSEcCtD
Paliperidone—Leukopenia—Etoposide—brain cancer	0.000344	0.00126	CcSEcCtD
Paliperidone—Diarrhoea—Hydroxyurea—brain cancer	0.000343	0.00126	CcSEcCtD
Paliperidone—Decreased appetite—Temozolomide—brain cancer	0.000341	0.00125	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Temozolomide—brain cancer	0.000338	0.00124	CcSEcCtD
Paliperidone—Fatigue—Temozolomide—brain cancer	0.000338	0.00124	CcSEcCtD
Paliperidone—Loss of consciousness—Etoposide—brain cancer	0.000338	0.00124	CcSEcCtD
Paliperidone—Cough—Etoposide—brain cancer	0.000335	0.00123	CcSEcCtD
Paliperidone—Constipation—Temozolomide—brain cancer	0.000335	0.00123	CcSEcCtD
Paliperidone—Pain—Temozolomide—brain cancer	0.000335	0.00123	CcSEcCtD
Paliperidone—Feeling abnormal—Carmustine—brain cancer	0.000334	0.00123	CcSEcCtD
Paliperidone—Convulsion—Etoposide—brain cancer	0.000333	0.00122	CcSEcCtD
Paliperidone—Hypertension—Etoposide—brain cancer	0.000332	0.00122	CcSEcCtD
Paliperidone—Dizziness—Hydroxyurea—brain cancer	0.000332	0.00122	CcSEcCtD
Paliperidone—Gastrointestinal pain—Carmustine—brain cancer	0.000332	0.00122	CcSEcCtD
Paliperidone—Chest pain—Etoposide—brain cancer	0.000327	0.0012	CcSEcCtD
Paliperidone—CYP3A4—endocrine gland—brain cancer	0.000327	0.00118	CbGeAlD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000325	0.00119	CcSEcCtD
Paliperidone—Discomfort—Etoposide—brain cancer	0.000323	0.00119	CcSEcCtD
Paliperidone—Feeling abnormal—Temozolomide—brain cancer	0.000323	0.00119	CcSEcCtD
Paliperidone—CYP2D6—endocrine gland—brain cancer	0.000321	0.00116	CbGeAlD
Paliperidone—Abdominal pain—Carmustine—brain cancer	0.000321	0.00118	CcSEcCtD
Paliperidone—Body temperature increased—Carmustine—brain cancer	0.000321	0.00118	CcSEcCtD
Paliperidone—Gastrointestinal pain—Temozolomide—brain cancer	0.000321	0.00118	CcSEcCtD
Paliperidone—Vomiting—Hydroxyurea—brain cancer	0.000319	0.00117	CcSEcCtD
Paliperidone—HTR2A—central nervous system—brain cancer	0.000318	0.00115	CbGeAlD
Paliperidone—CYP2D6—head—brain cancer	0.000317	0.00115	CbGeAlD
Paliperidone—Rash—Hydroxyurea—brain cancer	0.000316	0.00116	CcSEcCtD
Paliperidone—Confusional state—Etoposide—brain cancer	0.000316	0.00116	CcSEcCtD
Paliperidone—Dermatitis—Hydroxyurea—brain cancer	0.000316	0.00116	CcSEcCtD
Paliperidone—Headache—Hydroxyurea—brain cancer	0.000314	0.00115	CcSEcCtD
Paliperidone—Anaphylactic shock—Etoposide—brain cancer	0.000314	0.00115	CcSEcCtD
Paliperidone—Infection—Etoposide—brain cancer	0.000312	0.00114	CcSEcCtD
Paliperidone—Urticaria—Temozolomide—brain cancer	0.000311	0.00114	CcSEcCtD
Paliperidone—HTR2A—cerebellum—brain cancer	0.000311	0.00113	CbGeAlD
Paliperidone—Abdominal pain—Temozolomide—brain cancer	0.00031	0.00114	CcSEcCtD
Paliperidone—Body temperature increased—Temozolomide—brain cancer	0.00031	0.00114	CcSEcCtD
Paliperidone—Thrombocytopenia—Etoposide—brain cancer	0.000307	0.00113	CcSEcCtD
Paliperidone—Tachycardia—Etoposide—brain cancer	0.000306	0.00112	CcSEcCtD
Paliperidone—Skin disorder—Etoposide—brain cancer	0.000305	0.00112	CcSEcCtD
Paliperidone—HRH1—brain—brain cancer	0.000302	0.00109	CbGeAlD
Paliperidone—Anorexia—Etoposide—brain cancer	0.000299	0.0011	CcSEcCtD
Paliperidone—Hypersensitivity—Carmustine—brain cancer	0.000299	0.0011	CcSEcCtD
Paliperidone—Nausea—Hydroxyurea—brain cancer	0.000298	0.00109	CcSEcCtD
Paliperidone—ADRA2A—brain—brain cancer	0.000297	0.00108	CbGeAlD
Paliperidone—CYP3A4—central nervous system—brain cancer	0.000294	0.00107	CbGeAlD
Paliperidone—Hypotension—Etoposide—brain cancer	0.000293	0.00108	CcSEcCtD
Paliperidone—Asthenia—Carmustine—brain cancer	0.000291	0.00107	CcSEcCtD
Paliperidone—CYP2D6—central nervous system—brain cancer	0.00029	0.00105	CbGeAlD
Paliperidone—Hypersensitivity—Temozolomide—brain cancer	0.000289	0.00106	CcSEcCtD
Paliperidone—CYP2D6—cerebellum—brain cancer	0.000283	0.00103	CbGeAlD
Paliperidone—Paraesthesia—Etoposide—brain cancer	0.000282	0.00103	CcSEcCtD
Paliperidone—Asthenia—Temozolomide—brain cancer	0.000281	0.00103	CcSEcCtD
Paliperidone—Dyspnoea—Etoposide—brain cancer	0.00028	0.00103	CcSEcCtD
Paliperidone—Somnolence—Etoposide—brain cancer	0.000279	0.00102	CcSEcCtD
Paliperidone—Diarrhoea—Carmustine—brain cancer	0.000278	0.00102	CcSEcCtD
Paliperidone—Pruritus—Temozolomide—brain cancer	0.000277	0.00102	CcSEcCtD
Paliperidone—Decreased appetite—Etoposide—brain cancer	0.000273	0.001	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Etoposide—brain cancer	0.000271	0.000995	CcSEcCtD
Paliperidone—Fatigue—Etoposide—brain cancer	0.00027	0.000993	CcSEcCtD
Paliperidone—Dizziness—Carmustine—brain cancer	0.000268	0.000985	CcSEcCtD
Paliperidone—Pain—Etoposide—brain cancer	0.000268	0.000985	CcSEcCtD
Paliperidone—Constipation—Etoposide—brain cancer	0.000268	0.000985	CcSEcCtD
Paliperidone—Diarrhoea—Temozolomide—brain cancer	0.000268	0.000985	CcSEcCtD
Paliperidone—Dizziness—Temozolomide—brain cancer	0.000259	0.000952	CcSEcCtD
Paliperidone—Feeling abnormal—Etoposide—brain cancer	0.000259	0.00095	CcSEcCtD
Paliperidone—Vomiting—Carmustine—brain cancer	0.000258	0.000947	CcSEcCtD
Paliperidone—Gastrointestinal pain—Etoposide—brain cancer	0.000257	0.000942	CcSEcCtD
Paliperidone—Rash—Carmustine—brain cancer	0.000256	0.00094	CcSEcCtD
Paliperidone—Dermatitis—Carmustine—brain cancer	0.000256	0.000939	CcSEcCtD
Paliperidone—Headache—Carmustine—brain cancer	0.000254	0.000933	CcSEcCtD
Paliperidone—HTR2A—brain—brain cancer	0.000252	0.000914	CbGeAlD
Paliperidone—Vomiting—Temozolomide—brain cancer	0.000249	0.000916	CcSEcCtD
Paliperidone—Urticaria—Etoposide—brain cancer	0.000249	0.000915	CcSEcCtD
Paliperidone—Body temperature increased—Etoposide—brain cancer	0.000248	0.000911	CcSEcCtD
Paliperidone—Abdominal pain—Etoposide—brain cancer	0.000248	0.000911	CcSEcCtD
Paliperidone—Rash—Temozolomide—brain cancer	0.000247	0.000908	CcSEcCtD
Paliperidone—Dermatitis—Temozolomide—brain cancer	0.000247	0.000907	CcSEcCtD
Paliperidone—Headache—Temozolomide—brain cancer	0.000246	0.000902	CcSEcCtD
Paliperidone—Nausea—Carmustine—brain cancer	0.000241	0.000885	CcSEcCtD
Paliperidone—Nausea—Temozolomide—brain cancer	0.000233	0.000855	CcSEcCtD
Paliperidone—Hypersensitivity—Etoposide—brain cancer	0.000231	0.000849	CcSEcCtD
Paliperidone—CYP2D6—brain—brain cancer	0.00023	0.000833	CbGeAlD
Paliperidone—Asthenia—Etoposide—brain cancer	0.000225	0.000827	CcSEcCtD
Paliperidone—Pruritus—Etoposide—brain cancer	0.000222	0.000815	CcSEcCtD
Paliperidone—Diarrhoea—Etoposide—brain cancer	0.000215	0.000788	CcSEcCtD
Paliperidone—Dizziness—Etoposide—brain cancer	0.000207	0.000762	CcSEcCtD
Paliperidone—Vomiting—Etoposide—brain cancer	0.000199	0.000733	CcSEcCtD
Paliperidone—Rash—Etoposide—brain cancer	0.000198	0.000727	CcSEcCtD
Paliperidone—Dermatitis—Etoposide—brain cancer	0.000198	0.000726	CcSEcCtD
Paliperidone—Headache—Etoposide—brain cancer	0.000197	0.000722	CcSEcCtD
Paliperidone—Nausea—Etoposide—brain cancer	0.000186	0.000684	CcSEcCtD
Paliperidone—ADRA2C—Hemostasis—TP53—brain cancer	1.71e-05	0.000217	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—PDGFRA—brain cancer	1.71e-05	0.000217	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—BSG—brain cancer	1.71e-05	0.000216	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—PDGFRA—brain cancer	1.7e-05	0.000215	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—IL2—brain cancer	1.69e-05	0.000213	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—SPP1—brain cancer	1.66e-05	0.00021	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—IL2—brain cancer	1.66e-05	0.00021	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—PDGFRA—brain cancer	1.66e-05	0.00021	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—SPP1—brain cancer	1.65e-05	0.000209	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—VAV1—brain cancer	1.64e-05	0.000208	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—IL2—brain cancer	1.64e-05	0.000207	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	1.63e-05	0.000206	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—EGFR—brain cancer	1.62e-05	0.000205	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—SPP1—brain cancer	1.61e-05	0.000203	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—EGFR—brain cancer	1.59e-05	0.000201	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—SPP1—brain cancer	1.58e-05	0.0002	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—IL2—brain cancer	1.58e-05	0.0002	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—HES1—brain cancer	1.58e-05	0.0002	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—IL2—brain cancer	1.57e-05	0.000199	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—EGFR—brain cancer	1.56e-05	0.000198	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IRS2—brain cancer	1.56e-05	0.000197	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—HES1—brain cancer	1.55e-05	0.000196	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—HES1—brain cancer	1.55e-05	0.000196	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—APC—brain cancer	1.54e-05	0.000195	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—PIK3CG—brain cancer	1.54e-05	0.000195	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PIK3CG—brain cancer	1.54e-05	0.000194	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL2—brain cancer	1.53e-05	0.000194	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—IL2—brain cancer	1.53e-05	0.000193	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—PIK3CG—brain cancer	1.52e-05	0.000193	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—APC—brain cancer	1.52e-05	0.000193	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—HES1—brain cancer	1.52e-05	0.000192	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL2—brain cancer	1.51e-05	0.00019	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—IL2—brain cancer	1.51e-05	0.00019	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—PDGFRA—brain cancer	1.5e-05	0.00019	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IRS2—brain cancer	1.5e-05	0.00019	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—IL2—brain cancer	1.5e-05	0.00019	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IRS2—brain cancer	1.5e-05	0.000189	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—PDGFRA—brain cancer	1.48e-05	0.000187	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—PDGFRA—brain cancer	1.48e-05	0.000187	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—IL2—brain cancer	1.47e-05	0.000186	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—IDH1—brain cancer	1.47e-05	0.000185	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—SPP1—brain cancer	1.46e-05	0.000185	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IRS2—brain cancer	1.46e-05	0.000184	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	1.45e-05	0.000183	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—SPP1—brain cancer	1.44e-05	0.000182	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—SPP1—brain cancer	1.43e-05	0.000181	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IRS2—brain cancer	1.43e-05	0.000181	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—HES1—brain cancer	1.41e-05	0.000179	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—EGFR—brain cancer	1.41e-05	0.000178	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—SPP1—brain cancer	1.41e-05	0.000178	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—TP53—brain cancer	1.39e-05	0.000176	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—RELA—brain cancer	1.39e-05	0.000176	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL2—brain cancer	1.39e-05	0.000176	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—EGFR—brain cancer	1.39e-05	0.000176	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—ERBB2—brain cancer	1.38e-05	0.000175	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	1.38e-05	0.000174	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—APC—brain cancer	1.38e-05	0.000174	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—IL2—brain cancer	1.37e-05	0.000173	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL2—brain cancer	1.37e-05	0.000173	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL2—brain cancer	1.36e-05	0.000172	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—RELA—brain cancer	1.36e-05	0.000172	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—ERBB2—brain cancer	1.35e-05	0.000171	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	1.35e-05	0.00017	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—RELA—brain cancer	1.34e-05	0.000169	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL2—brain cancer	1.34e-05	0.000169	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—ERBB2—brain cancer	1.33e-05	0.000168	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—APC—brain cancer	1.33e-05	0.000168	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—PIK3CG—brain cancer	1.33e-05	0.000168	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—APC—brain cancer	1.32e-05	0.000167	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—PIK3CG—brain cancer	1.32e-05	0.000167	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IRS2—brain cancer	1.32e-05	0.000167	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SPP1—brain cancer	1.31e-05	0.000165	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IRS2—brain cancer	1.3e-05	0.000164	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IRS2—brain cancer	1.3e-05	0.000164	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	1.29e-05	0.000162	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—APC—brain cancer	1.29e-05	0.000162	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IRS2—brain cancer	1.27e-05	0.000161	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—APC—brain cancer	1.26e-05	0.00016	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	1.26e-05	0.00016	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—EGFR—brain cancer	1.25e-05	0.000158	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL2—brain cancer	1.25e-05	0.000158	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PIK3CG—brain cancer	1.25e-05	0.000158	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL2—brain cancer	1.24e-05	0.000157	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL2—brain cancer	1.23e-05	0.000155	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CCND1—brain cancer	1.22e-05	0.000154	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—EGFR—brain cancer	1.21e-05	0.000153	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CTNNB1—brain cancer	1.21e-05	0.000153	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL2—brain cancer	1.21e-05	0.000153	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—RELA—brain cancer	1.21e-05	0.000153	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.2e-05	0.000152	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—ERBB2—brain cancer	1.2e-05	0.000152	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CCND1—brain cancer	1.2e-05	0.000151	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—RELA—brain cancer	1.19e-05	0.000151	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CTNNB1—brain cancer	1.18e-05	0.00015	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—ERBB2—brain cancer	1.18e-05	0.00015	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IRS2—brain cancer	1.18e-05	0.000149	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CCND1—brain cancer	1.18e-05	0.000149	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—EGFR—brain cancer	1.17e-05	0.000148	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.17e-05	0.000147	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—APC—brain cancer	1.17e-05	0.000147	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CTNNB1—brain cancer	1.17e-05	0.000147	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ENO2—brain cancer	1.16e-05	0.000147	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—EGFR—brain cancer	1.15e-05	0.000146	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1.15e-05	0.000145	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—APC—brain cancer	1.15e-05	0.000145	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—APC—brain cancer	1.14e-05	0.000145	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—PIK3CG—brain cancer	1.14e-05	0.000145	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PIK3CG—brain cancer	1.14e-05	0.000145	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	1.12e-05	0.000142	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—APC—brain cancer	1.12e-05	0.000142	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL2—brain cancer	1.09e-05	0.000137	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—RELA—brain cancer	1.08e-05	0.000136	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL2—brain cancer	1.07e-05	0.000136	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—ERBB2—brain cancer	1.07e-05	0.000135	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—VEGFA—brain cancer	1.06e-05	0.000135	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—EGFR—brain cancer	1.06e-05	0.000134	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CCND1—brain cancer	1.06e-05	0.000134	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—STAT3—brain cancer	1.05e-05	0.000133	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CTNNB1—brain cancer	1.05e-05	0.000133	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CCND1—brain cancer	1.05e-05	0.000132	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—EGFR—brain cancer	1.05e-05	0.000132	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—APC—brain cancer	1.04e-05	0.000132	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	1.04e-05	0.000132	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—EGFR—brain cancer	1.04e-05	0.000132	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—VEGFA—brain cancer	1.04e-05	0.000132	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—RELA—brain cancer	1.04e-05	0.000131	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CTNNB1—brain cancer	1.04e-05	0.000131	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—STAT3—brain cancer	1.03e-05	0.000131	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—RELA—brain cancer	1.03e-05	0.000131	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—ERBB2—brain cancer	1.03e-05	0.00013	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—VEGFA—brain cancer	1.03e-05	0.00013	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—ERBB2—brain cancer	1.03e-05	0.00013	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—EGFR—brain cancer	1.02e-05	0.000129	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—STAT3—brain cancer	1.02e-05	0.000128	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—RELA—brain cancer	1e-05	0.000127	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—ERBB2—brain cancer	9.98e-06	0.000126	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—RELA—brain cancer	9.88e-06	0.000125	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—ERBB2—brain cancer	9.82e-06	0.000124	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—MYC—brain cancer	9.8e-06	0.000124	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL2—brain cancer	9.68e-06	0.000122	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—MYC—brain cancer	9.59e-06	0.000121	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—EGFR—brain cancer	9.58e-06	0.000121	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—EGFR—brain cancer	9.51e-06	0.00012	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—MYC—brain cancer	9.44e-06	0.000119	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CCND1—brain cancer	9.44e-06	0.000119	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—EGFR—brain cancer	9.38e-06	0.000119	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	9.35e-06	0.000118	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL2—brain cancer	9.35e-06	0.000118	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL2—brain cancer	9.3e-06	0.000118	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—VEGFA—brain cancer	9.24e-06	0.000117	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—EGFR—brain cancer	9.23e-06	0.000117	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—STAT3—brain cancer	9.15e-06	0.000116	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—VEGFA—brain cancer	9.11e-06	0.000115	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—RELA—brain cancer	9.11e-06	0.000115	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CCND1—brain cancer	9.11e-06	0.000115	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CCND1—brain cancer	9.06e-06	0.000115	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—ERBB2—brain cancer	9.05e-06	0.000114	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL2—brain cancer	9.04e-06	0.000114	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—STAT3—brain cancer	9.02e-06	0.000114	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CTNNB1—brain cancer	9.02e-06	0.000114	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CTNNB1—brain cancer	8.98e-06	0.000113	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—RELA—brain cancer	8.97e-06	0.000113	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—RELA—brain cancer	8.95e-06	0.000113	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—ERBB2—brain cancer	8.91e-06	0.000113	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL2—brain cancer	8.9e-06	0.000113	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—ERBB2—brain cancer	8.89e-06	0.000112	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CCND1—brain cancer	8.82e-06	0.000111	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—RELA—brain cancer	8.78e-06	0.000111	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	8.73e-06	0.00011	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—ERBB2—brain cancer	8.72e-06	0.00011	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CCND1—brain cancer	8.68e-06	0.00011	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	8.59e-06	0.000109	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—MYC—brain cancer	8.5e-06	0.000107	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MYC—brain cancer	8.39e-06	0.000106	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—EGFR—brain cancer	8.31e-06	0.000105	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—VEGFA—brain cancer	8.23e-06	0.000104	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL2—brain cancer	8.21e-06	0.000104	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—EGFR—brain cancer	8.2e-06	0.000104	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—RELA—brain cancer	8.16e-06	0.000103	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—STAT3—brain cancer	8.15e-06	0.000103	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PIK3CG—brain cancer	8.13e-06	0.000103	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—ERBB2—brain cancer	8.11e-06	0.000102	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL2—brain cancer	8.07e-06	0.000102	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL2—brain cancer	8.06e-06	0.000102	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TP53—brain cancer	8.05e-06	0.000102	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCND1—brain cancer	8e-06	0.000101	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—VEGFA—brain cancer	7.94e-06	0.0001	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CTNNB1—brain cancer	7.92e-06	0.0001	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL2—brain cancer	7.91e-06	9.99e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—VEGFA—brain cancer	7.9e-06	9.99e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TP53—brain cancer	7.88e-06	9.96e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCND1—brain cancer	7.87e-06	9.95e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—STAT3—brain cancer	7.86e-06	9.94e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCND1—brain cancer	7.85e-06	9.93e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—STAT3—brain cancer	7.82e-06	9.89e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CTNNB1—brain cancer	7.79e-06	9.85e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CTNNB1—brain cancer	7.78e-06	9.83e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TP53—brain cancer	7.75e-06	9.8e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCND1—brain cancer	7.71e-06	9.74e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—VEGFA—brain cancer	7.69e-06	9.72e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	7.63e-06	9.65e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—STAT3—brain cancer	7.61e-06	9.62e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MYC—brain cancer	7.57e-06	9.57e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—VEGFA—brain cancer	7.56e-06	9.56e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—STAT3—brain cancer	7.49e-06	9.47e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—EGFR—brain cancer	7.4e-06	9.36e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL2—brain cancer	7.35e-06	9.29e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MYC—brain cancer	7.31e-06	9.24e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MYC—brain cancer	7.27e-06	9.19e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCND1—brain cancer	7.16e-06	9.05e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—EGFR—brain cancer	7.15e-06	9.04e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—EGFR—brain cancer	7.11e-06	8.99e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	7.09e-06	8.96e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MYC—brain cancer	7.07e-06	8.94e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TP53—brain cancer	6.98e-06	8.82e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—VEGFA—brain cancer	6.97e-06	8.82e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MYC—brain cancer	6.96e-06	8.8e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—EGFR—brain cancer	6.92e-06	8.74e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—STAT3—brain cancer	6.91e-06	8.73e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TP53—brain cancer	6.89e-06	8.71e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—VEGFA—brain cancer	6.86e-06	8.67e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—VEGFA—brain cancer	6.85e-06	8.66e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—EGFR—brain cancer	6.81e-06	8.61e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—STAT3—brain cancer	6.79e-06	8.59e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—STAT3—brain cancer	6.78e-06	8.57e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—VEGFA—brain cancer	6.72e-06	8.49e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—STAT3—brain cancer	6.65e-06	8.41e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MYC—brain cancer	6.42e-06	8.11e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MYC—brain cancer	6.31e-06	7.98e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MYC—brain cancer	6.3e-06	7.96e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—EGFR—brain cancer	6.28e-06	7.93e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—VEGFA—brain cancer	6.24e-06	7.89e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TP53—brain cancer	6.22e-06	7.86e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MYC—brain cancer	6.18e-06	7.82e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—STAT3—brain cancer	6.18e-06	7.81e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—EGFR—brain cancer	6.18e-06	7.81e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—EGFR—brain cancer	6.16e-06	7.79e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—EGFR—brain cancer	6.05e-06	7.64e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TP53—brain cancer	6e-06	7.59e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TP53—brain cancer	5.97e-06	7.55e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TP53—brain cancer	5.81e-06	7.34e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MYC—brain cancer	5.74e-06	7.26e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TP53—brain cancer	5.72e-06	7.23e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—EGFR—brain cancer	5.62e-06	7.1e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PIK3CG—brain cancer	5.32e-06	6.72e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TP53—brain cancer	5.27e-06	6.66e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TP53—brain cancer	5.18e-06	6.55e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TP53—brain cancer	5.17e-06	6.54e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TP53—brain cancer	5.08e-06	6.42e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TP53—brain cancer	4.72e-06	5.96e-05	CbGpPWpGaD
